8th ESMRMB-GREC meeting
Clinical indications and safety of GBCA-enhanced MRI

Programm

• 08:30 – 08:45 15 Min. 0 Min.

  • Lecture

  Gadolinium-based contrast agents in the diagnosis and monitoring of the ear and internal auditory canal

  • Marinella Neri (Trento, IT)
  • Andrea Falzone (Rovereto, IT)
• 08:45 – 09:00 0 Min. 15 Min.

  • Discussion

  GREC Discussion
• 09:00 – 09:15 15 Min. 0 Min.

  • Lecture

  Gadolinium use reduction strategies in the clinical setting – state-of-the-art – ESUR-CMSC joint initiative

  • Ilona A. Dekkers (Amsterdam, NL)
• 09:15 – 09:30 15 Min. 0 Min.

  • Lecture

  ESUR-CMSC and ESMRMB-GREC Joint Working Group on GBCA Dose Reduction in MRI – Technical MRI optimisation

  • Aart J. van der Molen (Leiden, NL)
• 09:30 – 09:50 0 Min. 20 Min.

  • Discussion

  GREC Discussion
• 09:50 – 10:00 10 Min. 0 Min.

  • Lecture

  Multiorgan and plasma metabolomics for the investigation of the biological effects of gadodiamide and gadoteridol in healthy mice

  • Eliana Gianolio (Turin, IT)
• 10:00 – 10:10 10 Min. 0 Min.

  • Lecture

  Evaluating gadolinium-induced histopathological alterations related to small fiber neuropathy and gadolinium clearance following repeated GBCA administration in rats

  • Hubertus Pietsch (Bayer, DE)
• 10:10 – 10:20 10 Min. 0 Min.

  • Lecture

  Investigation of the gadolinium distribution in human nerves by mass spectrometric imaging

  • Christine Verlemann (Münster, DE)
  • Astrid Jeibmann (Münster, DE)
  • Uwe Karst (Münster, DE)
• 10:20 – 10:30 10 Min. 0 Min.

  • Lecture

  Disability and long-term clinical outcome in patients with Multiple Sclerosis and evidence of gadolinium retention in the brain

  • Sirio Cocozza (Naples, IT)
• 10:30 – 10:40 10 Min. 0 Min.

  • Lecture

  Imaging of meningeal lymphatics with standard clinical MRI and intravenous GBCA administrations

  • Michael Stringer (Edinburgh, GB)
• 10:40 – 10:50 10 Min. 0 Min.

  • Lecture

  MultiCriteria Decision Analysis (MCDA) model for GBCA

  • Anand Bherwani (GE HealthCare)
  • François Tranquart (GE HealthCare)
• 10:50 – 11:15 0 Min. 25 Min.

  • Discussion

  Questions and remarks